Generally, GLS1 is highly expressed in many types of cancers, including MM, and previous studies have shown that inhibition of glutamine metabolism impairs MM cell survival and overcomes drug resistance in vitro [12–14], but the detailed mechanism in vivo are still insufficient. The gene discussed is GLS; the disease is Miyoshi myopathy.